Bepotastine Besilate Structural Formula (Image 01)
Bepotastine Besilate Solution/ Drops
Product Images NDC 0378-7055
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bepotastine Besilate (NDC 0378-7055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Bepotastine Besilate Ophthalmic Solution 1.5% Carton Label (Image 02)
Bepotastine Besilate Ophthalmic Solution is a sterile prescription medication containing 1.5% Bepotastine for topical applications in the eye. It is administered by inserting one drop into the affected eye(s) twice a day. The medication includes preservative benzalkonium chloride at 0.005% and inactive substances such as monobasic sodium phosphate dihydrate, sodium chloride, sodium hydroxide to adjust pH levels and water for injection. The usual dosage, contraindications, and precautions are stated in the prescribing information that comes with the product. This medication should be kept in its unopened container and stored at 15-25°C. It is manufactured by Mylan Inc. in West Virginia, USA.*
Instructions For Use Figure A (Image 03)
The text describes the packaging design of a bottle cap that includes a tamper-evident tear-off ring. The cap can be used to seal a bottle. The text also includes a reference to Fig. A, which likely shows a visual representation of the cap and its tamper-evident feature.*
Instructions For Use Figure B (Image 04)
Instructions For Use Figure C (Image 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
